Mandate

Vinge advises Aspiro in connection with a public takeover offer from S. Carter Enterprises

February 01, 2015

Vinge advises Aspiro AB (publ) in connection with the public takeover offer from Project Panther Bidco Ltd, indirectly owned by  S. Carter Enterprises, LLC, which is controlled by Shawn Carter. All shareholders of Aspiro are offered SEK 1.05 in cash per share in Aspiro and the total value of the offer amounts to approx. MSEK 464. The acceptance period for the offer is expected to begin on or about 19 February 2015 and expire on or about 11 March 2015. The offer is, inter alia, conditional upon that it is accepted to the extent that Panther becomes the owner of more than 90 per cent of the total number of shares in Aspiro and that Panther receives the necessary regulatory approvals for the acquisition.

Vinge’s team primarily consisted of Jesper Schönbeck, Johan Rickfors and Nils Fredrik Dehlin.

Aspiro is a media technology company in the forefront of the ongoing redefinition of music consumption. Through the subscription services WiMP and TIDAL, Aspiro offers a complete experience of higher HiFi quality. The platform encompasses audio, video and integrated editorial features. In parallel, Aspiro is a content provider to the online media industry through RADR, helping its partners to attract and retain visitors on their web sites. For more information, please visit www.aspiro.com

 

Related

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025

Vinge has assisted PulPac in connection with it obtaining a €20 million financing from the European Investment Bank

Vinge has assisted Gothenburg-based sustainable packaging technology company PulPac in connection with it obtaining a €20 million (around 220 million Swedish kronor) financing from the European Investment Bank (EIB).
July 18, 2025